P723 Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
Reenaers, C, Cremer, A, Dewit, O, de Vroey, B, Van Moerkercke, W, Bossuyt, P, Muls, V, Imschoot, J, Block, S, Hantson, A, Van Hootegem, PVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.850
Date:
January, 2018
File:
PDF, 636 KB
english, 2018